NLS Pharmaceutics Ltd (NLSP)
0.174
0.00 (0.00%)
USD |
NASDAQ |
May 24, 16:00
0.1705
0.00 (0.00%)
After-Hours: 20:00
NLS Pharmaceutics Accounts Payable (Quarterly): 4.634M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.634M |
| June 30, 2023 | 3.113M |
| June 30, 2023 | 3.113M |
| December 31, 2022 | 2.373M |
| June 30, 2022 | 2.522M |
| June 30, 2022 | 2.522M |
| December 31, 2021 | 1.737M |
| June 30, 2021 | 0.5272M |
| Date | Value |
|---|---|
| June 30, 2021 | 0.5272M |
| December 31, 2020 | 4.006M |
| June 30, 2020 | 2.756M |
| June 30, 2020 | 2.756M |
| December 31, 2019 | 2.509M |
| June 30, 2019 | 1.854M |
| June 30, 2019 | 1.854M |
| December 31, 2018 | 1.131M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.5272M
Minimum
Jun 2021
4.634M
Maximum
Dec 2023
2.454M
Average
2.522M
Median
Jun 2022
Accounts Payable (Quarterly) Benchmarks
| AC Immune SA | 3.144M |
| CRISPR Therapeutics AG | 16.46M |
| Addex Therapeutics Ltd | 1.172M |
| Molecular Partners AG | 3.556M |
| MoonLake Immunotherapeutics | 1.630M |